Research and Development
Sanofi lowers Q3 sales figures from 2015
October 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Cipro, Plavix, Sanofi, financial results
New treatment for leukaemia nullifies cancer cells
October 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boston, Cancer, Germany, Harvard, Mainz University, leukaemia
Sun Pharmaceuticals hit with recall of over 31 thousand bottles of anti-depressants
October 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, India, US, america, sun pharmaceutical
Novartis’ Zykadia more effective than chemo, new study shows
October 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alcensa, Novartis, Roche, Xalkori, ceritinib, crizotinib, lung cancer, zykadia
Nestlé appoints Paul Navarre as CEO of Nestlé Skin Health
October 12, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Nestle skin health, Paul Navarre, nestle
Tesaro’s ovarian cancer drug success threatens market rivals
October 12, 2016 Research and Development AbbVie, AstraZeneca, Pfizer, Roche, Tesaro, avastin, lynparza, niraparib, talazoparib, veliparib
Gamida Cell receives Breakthrough Therapy Designation from FDA
October 12, 2016 Research and Development Breakthrough Therapy Designation, FDA, Gamida Cell, leukaemia, lymphoma
Transgene announce key partnership with Merck KGaA and Pfizer
October 12, 2016 Research and Development Cancer, France, Merck Group, Pfizer, Transgene, avelumab, head, neck
NICE backs Celgene’s Otezla for psoriatic arthritis
October 12, 2016 Research and Development, Sales and Marketing Celgene, NICE, otezla
AstraZeneca forced to abandon Phase II trial
October 12, 2016 Research and Development AstraZeneca, Synairgen, asthma, cold, common cold
Sanofi appoint Alan Main to Executive Committee and Executive Vice President Consumer Healthcare
October 11, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Exelixis’ Cabometyx smashes Pfizer cancer drug in Phase II trial
October 11, 2016 Manufacturing and Production, Research and Development Cabometyx, Exelixis, Pfizer, Phase II, Sutent, advanced renal cell carcinoma
Takeda enters $790m cancer development deal
October 11, 2016 Manufacturing and Production, Research and Development Cancer, Crescendo Biologics, Takeda, clinical partnership, humabody
New UK & Ireland general manager for Teva
October 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, appointment
Educating pharma
October 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing educated, funding, medical education, transparency
